e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Novel mechanisms in the pathogenesis of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A novel model for spontaneous T cell-independent steroid-refractory asthma in genetically modified mice
J. Elzer, J. Jones, A. Jarnicki, R. Vlahos, M. Ernst, G. Anderson (Melbourne, Australia)
Source:
Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Session:
Novel mechanisms in the pathogenesis of asthma
Session type:
Thematic Poster Session
Number:
898
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Elzer, J. Jones, A. Jarnicki, R. Vlahos, M. Ernst, G. Anderson (Melbourne, Australia). A novel model for spontaneous T cell-independent steroid-refractory asthma in genetically modified mice. Eur Respir J 2009; 34: Suppl. 53, 898
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Susceptibility to asthma exacerbation induced by superantigen is critically dependent on bystander mucosal Vβ8 TCR T cells in TH2 immune mice
Source: Eur Respir J 2001; 18: Suppl. 33, 19s
Year: 2001
Pulmonary recruitment of antigen specific CD4+GFP+ T cells after adoptive transfer in a murine model of experimental asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Activin-A is a critical inducer of human CD4+ICOS+IL-10-secreting regulatory T cells that suppress allergen-driven T cell responses in vitro and experimental asthma in a humanized mouse model in vivo
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Modified mRNA encoding Foxp3 protects against allergic asthma in mice by rebalancing T helper cell responses through an IL-23 / IL-17A-dependent mechanism
Source: Annual Congress 2012 - Treating childhood asthma
Year: 2012
The effects of DC expressing PD-L1 on CD4+ T cell in a murine model of allergic airway disease
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
Alleviation of asthma in a murine model is associated with intrahepatic NKT and CD4 lymphocyte trapping: a potential role for the liver in the immune modulation of asthma
Source: Annual Congress 2008 - Airway cell biology
Year: 2008
Induction of T cell anergy by high dose allergen in allergic mice and underlying mechanism
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
Regulatory T cells suppress more effective th1-induced airway disease compared to Th2 responses
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Adoptive transfer of APC activated by CpG-ODN can prevent manifestations of asthma in a murine model
Source: Eur Respir J 2003; 22: Suppl. 45, 10s
Year: 2003
Improving of experimental allergic asthma by decreased Th2 responses in OGR-1 knockout mice
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease
Source: Eur Respir J 2007; 30: 383-390
Year: 2007
Macrophages induce an allergen-specific and long-term suppression in a mouse asthma model
Source: Eur Respir J 2005; 26: 1040-1046
Year: 2005
Interferon-γ-pretreated dendritic cells induced dual Th1 and Th2 responses and failed to prevent development of allergic airway inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 230s
Year: 2006
Role of regulatory T-cells (Tregs) in bacterial infection-induced lung fibrosis exacerbation in mice
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
IL-17R-deficient mice generate a Th2 response and altered leukocyte trafficking in a model of pulmonary inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 194s
Year: 2003
CD39/CD73 and the imbalance of Th17 and Tregs (regulatory T cells) in allergic asthma
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Retroviral gene transduction and adoptive transfer of antigen-specific CD4
+
T cells: a dissection of the mechanisms of airway smooth muscle remodeling in experimental asthma and a potential therapeutic tool
Source: Eur Respir J 2004; 24: Suppl. 48, 658s
Year: 2004
T cell clone transfer model for steroid resistant asthma
Source: Annual Congress 2011 - Animal models of airway inflammation
Year: 2011
Different Th1, Th2, Th17 and Treg associated chemokine local pattern expression in lung in a murine model of allergic inflammation
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Comprehensive characterisation of T helper cells, cytotoxic T cells and novel invariant T cell phenotypes in human asthma
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept